Inventor · disambiguated record
Dirk Block
Also filed as: BLOCK DIRK
23 granted patents·19 pending applications·99 citations·filing 2003–2022
94Inventor score
Files withROCHE DIAGNOSTICS OPERATIONS INC22ROCHE DIAGNOSTICS OPERATIONS7WIENHUES-THELEN URSULA-HENRIKE5BLOCK DIRK3ROCHE MOLECULAR SYSTEMS INC2
Top patents by PatentIndex Score
42 records- 0194US9868756B2Method for bisulfite treatmentEPIGENOMICS AG·Filed 2015·Granted Jan 16, 2018·14 cites·11 claims
- 0292US10488422B2Use of IGFBP-7 in the assessment of heart failureROCHE DIAGNOSTICS OPERATIONS INC·Filed 2016·Granted Nov 26, 2019·7 cites·17 claims
- 0390US10557858B2Biomarkers for risk prediction of mortalityROCHE DIAGNOSTICS OPERATIONS INC·Filed 2017·Granted Feb 11, 2020·8 cites·23 claims
- 0487US10996229B2Use of IGFBP-7 in the assessment of heart failureROCHE DIAGNOSTICS OPERATIONS INC·Filed 2019·Granted May 4, 2021·2 cites·16 claims
- 0586US7413855B2Method for bisulfite treatmentROCHE MOLECULAR SYSTEMS INC·Filed 2004·Granted Aug 19, 2008·27 cites·6 claims
- 0684US9394332B2Method for bisulfite treatmentMARKERT-HAHN CHRISTINE·Filed 2003·Granted Jul 19, 2016·15 cites·11 claims
- 0782US10234462B2Use of mimecan in the assessment of heart failureBLOCK DIRK·Filed 2012·Granted Mar 19, 2019·6 cites·14 claims
- 0881US10684291B2Biomarkers for risk assessment and treatment monitoring in heart failure patients guided by natriuretic peptidesROCHE DIAGNOSTICS OPERATIONS INC·Filed 2016·Granted Jun 16, 2020·2 cites·10 claims
- 0979US8691587B2Use of SFRP-3 in the assessment of heart failureWIENHUES-THELEN URSULA-HENRIKE·Filed 2010·Granted Apr 8, 2014·5 cites·19 claims
- 1076US8158349B2Method and device for purifying nucleic acidsBLOCK DIRK·Filed 2011·Granted Apr 17, 2012·5 cites·7 claims
- 1174US2022412991A1Identification of patients with abnormal fractional shorteningROCHE DIAGNOSTICS OPERATIONS INC·Filed 2022·Application pending·0 cites
- 1273US7897378B2Method and device for purifying nucleic acidsROCHE MOLECULAR SYSTEMS INC·Filed 2005·Granted Mar 1, 2011·4 cites·19 claims
- 1373US2023062697A1TnT BASED DIAGNOSIS OF PAROXYSMAL ATRIAL FIBRILLATIONROCHE DIAGNOSTICS OPERATIONS INC·Filed 2022·Application pending·0 cites
- 1471US2022206015A1Marker for statin treatment stratification in heart failureROCHE DIAGNOSTICS OPERATIONS INC·Filed 2022·Application pending·0 cites
- 1568US10942175B2Use of biomarkers in the assessment of the early transition from arterial hypertension to heart failureROCHE DIAGNOSTICS OPERATIONS INC·Filed 2014·Granted Mar 9, 2021·1 cites·12 claims
- 1668US8927261B2Method and device for purifying nucleic acidsBLOCK DIRK·Filed 2012·Granted Jan 6, 2015·2 cites·16 claims
- 1767US2022034910A1Biomarkers in the selection of therapy of heart failureROCHE DIAGNOSTICS OPERATIONS INC·Filed 2021·Application pending·0 cites
- 1866US11460474B2Marker for statin treatment stratification in heart failureROCHE DIAGNOSTICS OPERATIONS INC·Filed 2019·Granted Oct 4, 2022·0 cites·12 claims
- 1965US2021164969A1Use of Biomarkers in the Assessment of the Early Transition from Arterial Hypertension to Heart FailureROCHE DIAGNOSTICS OPERATIONS INC·Filed 2021·Application pending·0 cites
- 2062US12117454B2Biomarkers for risk assessment and treatment monitoring in heart failure patients guided by natriuretic peptidesROCHE DIAGNOSTICS OPERATIONS INC·Filed 2020·Granted Oct 15, 2024·0 cites·12 claims
- 2162US11047866B2IGFBP7 for diagnosing diastolic dysfunctionROCHE DIAGNOSTICS OPERATIONS INC·Filed 2019·Granted Jun 29, 2021·0 cites·10 claims
- 2262US2015293122A1Use of igfbp-7 in the assessment of heart failureROCHE DIAGNOSTICS OPERATIONS·Filed 2014·Application pending·0 cites
- 2360US9267954B2Use of SLIM-1 in the assessment of heart failureWIENHUES-THELEN URSULA-HENRIKE·Filed 2009·Granted Feb 23, 2016·1 cites·3 claims
- 2457US2010285491A1Use of igfbp-7 in the assessment of heart failureWIENHUES-THELEN URSULA-HENRIKE·Filed 2009·Application pending·0 cites
- 2557US2017074892A1TnT BASED DIAGNOSIS OF PAROXYSMAL ATRIAL FIBRILLATIONROCHE DIAGNOSTICS OPERATIONS INC·Filed 2016·Application pending·0 cites
- 2656US2018313850A1NTproBNP AND cTnT BASED THERAPY GUIDANCE IN HEART FAILUREROCHE DIAGNOSTICS OPERATIONS INC·Filed 2018·Application pending·0 cites
- 2756US2014193845A1Use of sfrp-3 in the assessment of heart failureUNIV TORONTO·Filed 2014·Application pending·0 cites
- 2855US11454634B2Assessing whether a subject shall be subjected to imaging based diagnosticROCHE DIAGNOSTICS OPERATIONS INC·Filed 2018·Granted Sep 27, 2022·0 cites·13 claims
- 2954US11874282B2IGFBP-7 as a marker of preeclampsiaROCHE DIAGNOSTICS OPERATIONS INC·Filed 2018·Granted Jan 16, 2024·0 cites·13 claims
- 3053US10345315B2IGFBP7 for diagnosing diastolic dysfunctionROCHE DIAGNOSTICS OPERATIONS INC·Filed 2016·Granted Jul 9, 2019·0 cites·10 claims
- 3153US2015185230A1Identification of patients with abnormal fractional shorteningROCHE DIAGNOSTICS OPERATIONS·Filed 2015·Application pending·0 cites
- 3253US2015233946A1TnT BASED DIAGNOSIS OF PAROXYSMAL ATRIAL FIBRILLATIONROCHE DIAGNOSTICS OPERATIONS·Filed 2015·Application pending·0 cites
- 3352US2014065648A1Use of biomarkers in the assessment of the early transition from arterial hypertension to heart failureROCHE DIAGNOSTICS OPERATIONS·Filed 2013·Application pending·0 cites
- 3450US10234464B2Marker for statin treatment stratification in heart failureROCHE DIAGNOSTICS OPERATIONS INC·Filed 2016·Granted Mar 19, 2019·0 cites·10 claims
- 3549US11644472B2Circulating Angiopoietin-2 (Ang-2) for the prediction of recurrence of atrial fibrillationROCHE DIAGNOSTICS OPERATIONS INC·Filed 2018·Granted May 9, 2023·0 cites·9 claims
- 3648US2015233945A1NTproBNP AND cTnT BASED THERAPY GUIDANCE IN HEART FAILUREROCHE DIAGNOSTICS OPERATIONS·Filed 2015·Application pending·0 cites
- 3742US11397187B2IGFBP7 for prediction of risk of AKI when measured prior to surgeryROCHE DIAGNOSTICS OPERATIONS INC·Filed 2018·Granted Jul 26, 2022·0 cites·12 claims
- 3842US2019279770A1Soluble st2 for the identification of progressors to lvh in the general populationROCHE DIAGNOSTICS OPERATIONS INC·Filed 2018·Application pending·0 cites
- 3939US2012009610A1Endostatin as a marker of heart failureWIENHUES-THELEN URSULA-HENRIKE·Filed 2011·Application pending·0 cites
- 4039US2015268251A1Biomarkers in the selection of therapy of heart failureROCHE DIAGNOSTICS OPERATIONS·Filed 2015·Application pending·0 cites
- 4137US2016146836A1Use of alpha-crystallin b (cryab) in the assessment of heart failureROCHE DIAGNOSTICS OPERATIONS·Filed 2016·Application pending·0 cites
- 4237US2011165591A1Use of biglycan in the assessment of heart failureWIENHUES-THELEN URSULA-HENRIKE·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Dirk Block files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →